港股異動 | 康哲藥業(0867.HK)急升超7% 斥近億元回購 且已消化此前做空情緒
格隆匯2月13日丨康哲藥業(0867.HK)今日股價高開上漲,一度急升至超7%。現漲5.35%,報11.02港元,暫成交1019.65萬港元,最新總市值273.34億港元。康哲藥業發佈公告,公司於2020年2月11日斥資9816.41萬港元回購964.8萬股,佔現有已發行股本0.389%。此外,近日沽空機構Blue Orca在報告中指出公司完全不值得投資。受此報告影響,康哲藥業當日股價出現盤中急跌,但跌幅很快收窄。公司火速回應稱,Blue Orca的指控均為基於不瞭解公司業務架構、可適用税收政策法規、審計流程等,公司強烈否認沽空機構報告的指控。今日公司股價再起升勢,已經收復此前遭做空時的跌幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.